Arden Trust CO Sage Therapeutics, Inc. Transaction History

Arden Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 09, 2020	SELL	$25.95 - $43.15 $1,557 - $2,589	-60 Closed	0 $0
Q1 2020 Apr 16, 2020	BUY	$26.15 - $77.24 $1,569 - $4,634	60 New	60 $2,000
Q4 2019 Jan 17, 2020	SELL	$60.18 - $154.77 $91,774 - $236,024	-1,525 Closed	0 $0
Q3 2019 Oct 09, 2019	BUY	$140.29 - $189.96 $140 - $189	1 Added 0.07%	1,525 $214,000
Q2 2019 Jul 23, 2019	BUY	$157.85 - $183.09 $240,563 - $279,029	1,524 New	1,524 $279,000

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $395M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Arden Trust CO, based on Form 13F filings with the SEC.

Stay updated on Arden Trust CO with notifications on news.